DeepMind’s Nobel-Winning AI Moves From Lab to Clinic

The transition of AlphaFold-designed molecules into human trials marks a pivotal shift from theoretical protein mapping to tangible medical breakthroughs. By significantly accelerating drug discovery through platforms like IsoDDE, AI is poised to fundamentally reshape the pharmaceutical industry’s efficiency and success rates.